Detalhe da pesquisa
1.
CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.
J Immunol
; 211(5): 735-742, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466381
2.
Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors.
J Natl Compr Canc Netw
; 2021 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348236
3.
A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance.
Clin Cancer Res
; 29(20): 4242-4255, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505479
4.
PhenoComb: a discovery tool to assess complex phenotypes in high-dimensional single-cell datasets.
Bioinform Adv
; 2(1): vbac052, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36699375
5.
Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics.
J Invest Dermatol
; 142(7): 1912-1922.e7, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942200
6.
Circulating CD8+ mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients.
Clin Transl Immunology
; 11(1): e1367, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028137
7.
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
J Immunother Cancer
; 10(11)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450385
8.
Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor-Resistant Melanoma.
Mol Cancer Ther
; 20(10): 2049-2060, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376578
9.
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.
Pharmaceuticals (Basel)
; 14(8)2021 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34451846
10.
Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.
Blood
; 112(3): 822-9, 2008 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18483394
11.
Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas.
Melanoma Res
; 30(6): 562-573, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156595
12.
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Cancers (Basel)
; 12(8)2020 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32764384
13.
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells.
Cell Death Dis
; 11(6): 443, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513939
14.
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy.
Cancers (Basel)
; 12(7)2020 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32708981
15.
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.
Nat Commun
; 11(1): 5259, 2020 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067454
16.
IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics.
BMC Med Genomics
; 11(Suppl 2): 26, 2018 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29697364
17.
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma.
Cell Death Dis
; 9(9): 907, 2018 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185782
18.
Effects of brief cutaneous JP-8 jet fuel exposures on time course of gene expression in the epidermis.
Toxicol Sci
; 95(2): 495-510, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17085751
19.
Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
Melanoma Res
; 27(3): 189-199, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28296713
20.
Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.
Oncotarget
; 7(51): 84594-84607, 2016 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27829238